Chemotherapy Flashcards
Fosfomycin
Inhibits MurA, which adds PEP to UDP-NAG to form UDP-NAG-EP.
D-cycloserine
Inhibits L-alanine racemase and D-alanine:D-alanine ligase, and MurF which adds D-Ala-D-Ala to UDP-NAM-L-Ala-D-Glu-L-Lys.
Bacitracin
Forms a tight complex with Mg2+ and bactoprenol pyrophosphate; inhibits the dephosphorylation to bactoprenol phosphate.
Penicillin, Cephalosporin, Monobactam, Carbapenem
Peptidoglycan transpeptidase (variant of serine hydrolases) mistakes penicillin for a yet to be cross-linked PG chain terminating in D-Ala-D-Ala. This is due to the similarity in configuration of the CO-N bond in penicillin and CO-N bond between D-Ala and D-Ala. An acyl-enzyme intermediate is still formed, but the acyl group is made of penicilloyl (penicillin with β-lactam ring opened). This acyl-enzyme intermediate is very slow to hydrolyse hence cross-linking is essentially inhibited. Cell wall autolysins continue to re-shape PG during cell growth and division, however this now induces lysis of the cell since new PG made is unstable. Hence only proliferating cells, in which autolysins are active, are sensitive to β-lactam antibiotics.
Vancomycin
Binds to D-Ala-D-Ala of pentapeptide in peptidoglycan via 5 H-bonds, preventing its cross-linking to a neighbouring pentapeptide in another peptidoglycan strand.
Used against clostridium difficile and Gram-positive cocci.
Extended spectrum cephalosporin
Active against Gram-positive bacteria with increased activity against Gram-negative bacteria.
Contains an oxyimino side chain which is more difficult to fit in the active site of β-lactamases.
Tetracycline (Tetracycline family)
Tetracycline forms electorstatic interactions with oxygen atoms in internucleotide phosphodiester links in 16S rRNA of the ribosome via a Mg2+ ion. Inhibits movement of aminoacyl tRNA into the A site after EF-Tu-GTP hydrolysis.
Broad-spectrum, first-line drugs against mycoplasma and cholera. Also effective against Plasmodium parasites.
Ribosomal protection proteins can dislodge tetracycline from ribosome.
Chloramphenicol (Amphenicol family)
Blocks aminoacyl tRNA binding to 50S subunit of ribosome.
Broad-spectrum antibiotic but use is restricted because of bone marrow suppression. Only for life-threatening infections such as meningitis.
Erythromycin, clarithromycin, azithromycin, tylosin (Macrolide family)
Binds to 23S rRNA in 50S subunit, and blocks the polypeptide exit tunnel, physically inhibiting elongation of polypeptide chain.
Similar antibacterial spectrum as penicillin, and is a second-line drug for patients allergic to penicillin.
Can be bacteriostatic or bactericidal.
Streptomycin, gentamycin, kanamycin, pararomycin (Aminoglycoside family)
Target 30S subunit of ribosome and decrease fidelity of mRNA translation. So aminoglycosides are bactericidal (others are bacteriostatic).
Streptomycin causes nephrotoxicity and ototoxicity (less for gentamycin).
Used for Gram-negative bacilli/rods.
Most streptococci are resistant because aminoglycosides cannot penetrate the cell. β-lactams disrupt cell membrane to increase passive diffusion of aminoglycoside. Penicillin and gentamycin (specifically) have a synergistic effect against some streptococci.
Note that a bactericidal (e.g penicillin) and bacteriostatic (e.g. tetracycline) will cause antagonism since penicillin only has effect on actively dividing cells.
Linezolid (Oxazolidinone family)
Interaction with the 23S ribosomal RNA of the 50S ribosomal subunit. Broad spectrum.
Spectinomycin (Aminocyclitol family)
Target 30S subunit of ribosome and inhibits EF-G function.
Clindamycin, lincomycin (Lincosamide family)
Targets 23S rRNA of 50S subunit. Binding site overlaps with macrolides and streptogramin B. No need to know function.
Effective against Plasmodium parasites.
Fusidic acid
Inhibits EF-G. Narrow spectrum, used against staphylococcal infections.
Synercid
Quinupristin + dalfopristin. Binds to 23S rRNA of 50S subunit to prevent polypeptide translocation.
Novobiocin, coumermycin A1 (Aminocoumarin family)
Targets GyrB subunit of DNA gyrase.
Ciprofloxacin, gatifloxacin, levofloxacin (Fluoroquinolone family)
Inhibits type II DNA topoisomerases (DNA gyrase and topo IV). Caused cleaved dsDNA to accumulate, replication forks are halted, bactericidal.
Ciprofloxacin used against Bacillus anthracis and Pseudomonas.
R-factor encoded quinolone resistance protein (QNR) physically blocks binding of antibiotic.
Rifampin/rifampicin
Binds to the DNA/RNA tunnel associated with the β subunit of DNA-dependent RNA polymerase. Physically inhibits RNA chain elongation.
Can block fungal DNA-dependent RNA polymerase, but needs help from polyene antibiotics to get through ergosterol membrane.
Upregulates PXR to increase CYP3A4 production.
Daunorubicin, doxorubicin (Anthracycline family)
Intercalates in dsDNA and causes local unwinding. Affects molecular dimensions of major and minor groove, prevents interaction of molecules with DNA necessary for DNA replication and transcription.
Has hydroxyquinone moiety so can generate free radicals which cause lipid peroxidation in cardiac tissue.
Bleomycin
Chelates Fe2+, producing a molecule that reacts with O2 to generate reactive radicals, causing single and double stranded breaks in DNA.
Especially toxic to Gram positives and mammalian cells.
Mitomycin C
Aziridine-containing antibiotic. Needs to be activated by reduction of the quinone group.
Alkylates guanine bases at GC positions in complementary DNA strands.
Causes cross-linking of two guanine bases, one on each strand, and prevents strand separation during DNA replication and transcription.
Sulfamethoxazole/Sulfadiazine
Inhibits bacterial DHPS. DHPS turns pABA into dihydropteroate.
DHPS absent in eukaryotes as we scavenge folate from dietary sources but bacteria have to make it de novo.
Trimethoprim
Inhibits bacterial DHFR. DHFR turns FH2 into FH4/THF, which is then converted into 5,10-methylene-FH4, which is used to maked dTMP.
Bacterial and mammalian DHFR has enough structural differences for selective inhibition.
Metabolic bypass: R plasmid-encoded DHPS and DHFR have a much lower binding affinity for the antibiotics than the normal bacterial enzymes.
Co-trimoxazole
Sulfamethoxazole + trimethoprim.
Sulfamethoxazole only shuts of de novo folate synthesis. Existing folate levels will take several bacterial generations to decline.
Adding trimethorpim traps folate in the useless FH2 form (5,10-methylene-FH4 becomes FH2 after being used to make dTMP). Rapid depletion of FH4 form.
Use isobologram to show effects of synergisim.
Valinomycin
Made of 3 repeating units of L-Lactate-L-Valine-D-Hydroxyisovalerate-D-Valine. Acts as a K+ uniporter.
Has the specificity: Rb+>K+>Na+>Li.
Nigercin
Acts as a K+/H+ antiporter.
Monensin
Acts as a Na+/H+ antiporter.
Gramicidin A
Forms a homodimeric complex in the membrane. Permits diffusion of monovalent cations with diameters up to 5Å.
Has the specificity: H+>Rb+>K+>Na+>Li.
Polymixin
Amphipathic molecule with a net charge of +5. Binds to negatively charged phosphate heads. Alters permeability of cytoplasmic membrane.
All antibiotics that target membranes act to dissipate transmembrane ion gradients and cause macromolecule leakage. An issue is the lack of selectivity as host cells also has a phospholipid bilayer.
Amphotericin B, nystatin
Binds and forms holes preferentially in ergosterol, which is found in fungi and parasties’ plasma membrane (e.g. Leishmania species), rather than cholesterol.
Fluconazole, miconazole
Inhibit enzymes involved in ergosterol biosynthesis. This alters fluidity and hence permeability of the membrane, and activity of membrane-bound enzymes.
Melarsoprol
Prodrug becomes melarsen oxide. Contains arsenic, reacts with dithiols in cofactors like lipoic acid and enzymes like pyruvate kinase and PFK, hence inhibiting ATP synthesis.
Preferentially toxic for Trypanosoma species which causes sleeping sickness.
Suramin
Has no toxic metal atom. Inhibits glycerol-3-phosphate oxidase and glycerol-3-phosphate dehydrogenase. This interferes with the reoxidation of NADH to NAD+ and hence inhibits ATP synthesis.
Also used against Trypanosoma species.
Chloroquine, mefloquine, primaquine
Trophozoite phase of Plasmodium, in RBCs, digest haemoglobin to obtain amino acids, which happens in the food vacuole. This produces haem as a toxic byproduct (since oxidation of iron in haem causes production of ROS). Parasite polymerises haem into non-toxic haemozoin.
Chloroquine inhibits haem polymerisation and raises pH in food vacuole, reducing metabolism.
R-factor encoded chloroquine resistance transporter (CRT) causes chloroquine efflux from food vacuole.
Artemisinin
Two hypotheses: (1) Endoperoxide bridge breaks and creates free radicals which causes metabolic stress.
(2) Inhibition of Plasmodium’s PfATP6. This leads to increased intracellular [Ca2+] and cell death.
Artemisinin-based Combination Therapies (ACT)
Artesunate + amodiaquine
Artemether + lumefantrine
Sulfadoxin
Inhibits Plasmodium DHPS.
Pyrimethamine
Inhibits Plasmodium DHFR.
Fansidar
Sulfadoxin + pyrimethamine.
Proguanil
Prodrug converted to cycloguanil. Inhibits Plasmodium DHFR.
RTS,S (Mosquirix)
Vaccine made from CSP protein of Plasmodium, viral envelope protein of Hepatitis B virus, with adjuvant AS01.
Amantadine, rimantadine
Block the function of the M2 channel protein, which is needed to acidify the endosome to promote nucleocapsid uncoating.
Used for influenza A virus. Not effective against influenza B virus.